ZHEJIANG QIANJIANG BIOCHEMICAL CO., LTD Zhejiang Qianjiang Biochemical Co., Ltd Share Price
Equities
600796
CNE000000PG1
Construction & Engineering
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.76 CNY | -0.42% |
|
+5.08% | -18.63% |
| Sales 2024 * | 2.38B 328M 27.4B | Sales 2025 * | 3B 415M 34.64B | Capitalization | 4.12B 570M 47.55B |
|---|---|---|---|---|---|
| Net income 2024 * | 248M 34.26M 2.86B | Net income 2025 * | 290M 40.06M 3.34B | EV / Sales 2024 * | 1.74 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.37 x |
| P/E ratio 2024 * |
16.4
x | P/E ratio 2025 * |
14.4
x | Employees | 3,306 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 21.75% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.42% | ||
| 1 week | +5.08% | ||
| Current month | -3.05% | ||
| 1 month | -3.05% | ||
| 3 months | -12.34% | ||
| 6 months | -11.52% | ||
| Current year | -18.63% |
1 week
4.38
4.87
1 month
4.205.15
Current year
3.656.07
1 year
3.656.65
3 years
3.657.10
5 years
3.657.41
10 years
3.6520.98
| Managers | Title | Age | Since |
|---|---|---|---|
Yu Chao Sun
CEO | Chief Executive Officer | 44 | 30/22/30 |
Yue Zhong Ma
DFI | Director of Finance/CFO | 49 | 30/22/30 |
Song Zhang
BRD | Director/Board Member | 50 | 30/22/30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jin Shan Zhu
PRN | Corporate Officer/Principal | 56 | 30/06/30 |
Qiang Yu
CHM | Chairman | 57 | 20/13/20 |
Bing Qi Zhu
BRD | Director/Board Member | 58 | 20/13/20 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/24/30 | 4.76 | -0.42% | 6,313,200 |
| 29/24/29 | 4.78 | +0.42% | 10,076,900 |
| 26/24/26 | 4.76 | -2.26% | 13,691,670 |
| 25/24/25 | 4.87 | +4.73% | 6,906,400 |
| 24/24/24 | 4.65 | +2.42% | 4,301,711 |
End-of-day quote Shanghai S.E., April 30, 2024
More quotes
Zhejiang Qianjiang Biochemical Co., Ltd. is a China-based company principally engaged in the production and sales of biological products. The Company's main products include bio-pesticide products, veterinary drug substances and preparations, as well as pharmaceutical intermediates. The Company is also engaged in the research and development, manufacturing and sales of steam from the combined heat and power generation, as well as the real estate business. The Company mainly operates its business in the domestic market.
Sector
Construction & Engineering
Calendar
10/05/2024
- Annual General Meeting
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.76
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -18.63% | 570M | |
| +116.92% | 677M | |
| +82.71% | 635M | |
| -10.47% | 544M | |
| -6.73% | 528M | |
| -11.07% | 440M | |
| -23.92% | 346M | |
| -50.68% | 288M | |
| +45.89% | 214M | |
| +11.33% | 171M |
- Stock Market
- Equities
- 600796 Stock
